156 related articles for article (PubMed ID: 9535168)
41. Propidium-based polyamine ligands as potent inhibitors of acetylcholinesterase and acetylcholinesterase-induced amyloid-beta aggregation.
Bolognesi ML; Andrisano V; Bartolini M; Banzi R; Melchiorre C
J Med Chem; 2005 Jan; 48(1):24-7. PubMed ID: 15633997
[TBL] [Abstract][Full Text] [Related]
42. New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease.
Camps P; El Achab R ; Morral J; Muñoz-Torrero D; Badia A; Baños JE; Vivas NM; Barril X; Orozco M; Luque FJ
J Med Chem; 2000 Nov; 43(24):4657-66. PubMed ID: 11101357
[TBL] [Abstract][Full Text] [Related]
43. Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids.
Bautista-Aguilera OM; Esteban G; Chioua M; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Soriano E; Samadi A; Unzeta M; Marco-Contelles J
Drug Des Devel Ther; 2014; 8():1893-910. PubMed ID: 25378907
[TBL] [Abstract][Full Text] [Related]
44. Drug Design of Inhibitors of Alzheimer's Disease (AD): POM and DFT Analyses of Cholinesterase Inhibitory Activity of β-amino di-Carbonyl Derivatives.
Hadda TB; Rauf A; Zgou H; Senol FS; Orhan IE; Mabkhot YN; Althagafi II; Farghaly TA; Alterary S
Mini Rev Med Chem; 2019; 19(8):688-705. PubMed ID: 30387392
[TBL] [Abstract][Full Text] [Related]
45. Synthesis, Molecular Modeling, and Evaluation of Novel Sulfonylhydrazones as Acetylcholinesterase Inhibitors for Alzheimer's Disease.
Fernandes TB; Cunha MR; Sakata RP; Candido TM; Baby AR; Tavares MT; Barbosa EG; Almeida WP; Parise-Filho R
Arch Pharm (Weinheim); 2017 Nov; 350(11):. PubMed ID: 28940630
[TBL] [Abstract][Full Text] [Related]
46. Microbial acetylcholinesterase inhibitors for Alzheimer's therapy: recent trends on extraction, detection, irradiation-assisted production improvement and nano-structured drug delivery.
Zaki AG; El-Sayed ER; Abd Elkodous M; El-Sayyad GS
Appl Microbiol Biotechnol; 2020 Jun; 104(11):4717-4735. PubMed ID: 32285176
[TBL] [Abstract][Full Text] [Related]
47. Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine.
Samadi A; de los Ríos C; Bolea I; Chioua M; Iriepa I; Moraleda I; Bartolini M; Andrisano V; Gálvez E; Valderas C; Unzeta M; Marco-Contelles J
Eur J Med Chem; 2012 Jun; 52():251-62. PubMed ID: 22503231
[TBL] [Abstract][Full Text] [Related]
48. Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles.
Eskander MF; Nagykery NG; Leung EY; Khelghati B; Geula C
Brain Res; 2005 Oct; 1060(1-2):144-52. PubMed ID: 16212945
[TBL] [Abstract][Full Text] [Related]
49. Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.
Shaik JB; Palaka BK; Penumala M; Kotapati KV; Devineni SR; Eadlapalli S; Darla MM; Ampasala DR; Vadde R; Amooru GD
Eur J Med Chem; 2016 Jan; 107():219-32. PubMed ID: 26588065
[TBL] [Abstract][Full Text] [Related]
50. Extracts from Traditional Chinese Medicinal Plants Inhibit Acetylcholinesterase, a Known Alzheimer's Disease Target.
Kaufmann D; Kaur Dogra A; Tahrani A; Herrmann F; Wink M
Molecules; 2016 Aug; 21(9):. PubMed ID: 27589716
[TBL] [Abstract][Full Text] [Related]
51. New tacrine-acridine hybrids as promising multifunctional drugs for potential treatment of Alzheimer's disease.
Chufarova N; Czarnecka K; Skibiński R; Cuchra M; Majsterek I; Szymański P
Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800050. PubMed ID: 29870588
[TBL] [Abstract][Full Text] [Related]
52. Structure and anti-acetylcholinesterase activity of 4 alpha-(hydroxymethyl)-4 alpha-demethylterritrem B.
Peng FC
J Nat Prod; 1997 Aug; 60(8):842-3. PubMed ID: 9287420
[TBL] [Abstract][Full Text] [Related]
53. Risk of antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine.
Suh DC; Arcona S; Thomas SK; Powers C; Rabinowicz AL; Shin H; Mirski D
Drugs Aging; 2004; 21(6):395-403. PubMed ID: 15084141
[TBL] [Abstract][Full Text] [Related]
54. Use of ligand-based pharmacophore modeling and docking approach to find novel acetylcholinesterase inhibitors for treating Alzheimer's.
Dhanjal JK; Sharma S; Grover A; Das A
Biomed Pharmacother; 2015 Apr; 71():146-52. PubMed ID: 25960230
[TBL] [Abstract][Full Text] [Related]
55. Modulators of Acetylcholinesterase Activity: From Alzheimer's Disease to Anti-Cancer Drugs.
Lazarevic-Pasti T; Leskovac A; Momic T; Petrovic S; Vasic V
Curr Med Chem; 2017; 24(30):3283-3309. PubMed ID: 28685687
[TBL] [Abstract][Full Text] [Related]
56. Design, Synthesis, and Biological Evaluation of Orally Available First-Generation Dual-Target Selective Inhibitors of Acetylcholinesterase (AChE) and Phosphodiesterase 5 (PDE5) for the Treatment of Alzheimer's Disease.
Mao F; Wang H; Ni W; Zheng X; Wang M; Bao K; Ling D; Li X; Xu Y; Zhang H; Li J
ACS Chem Neurosci; 2018 Feb; 9(2):328-345. PubMed ID: 29068218
[TBL] [Abstract][Full Text] [Related]
57. Structure-activity relationship studies of benzyl-, phenethyl-, and pyridyl-substituted tetrahydroacridin-9-amines as multitargeting agents to treat Alzheimer's disease.
Osman W; Mohamed T; Sit VM; Vasefi MS; Beazely MA; Rao PP
Chem Biol Drug Des; 2016 Nov; 88(5):710-723. PubMed ID: 27282589
[TBL] [Abstract][Full Text] [Related]
58. Avarol derivatives as competitive AChE inhibitors, non hepatotoxic and neuroprotective agents for Alzheimer's disease.
Tommonaro G; García-Font N; Vitale RM; Pejin B; Iodice C; Cañadas S; Marco-Contelles J; Oset-Gasque MJ
Eur J Med Chem; 2016 Oct; 122():326-338. PubMed ID: 27376495
[TBL] [Abstract][Full Text] [Related]
59. Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease.
Tasso B; Catto M; Nicolotti O; Novelli F; Tonelli M; Giangreco I; Pisani L; Sparatore A; Boido V; Carotti A; Sparatore F
Eur J Med Chem; 2011 Jun; 46(6):2170-84. PubMed ID: 21459491
[TBL] [Abstract][Full Text] [Related]
60. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.
Son M; Park C; Rampogu S; Zeb A; Lee KW
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
